RBOT
Vicarious Surgical Inc.
NYSE · Healthcare · Medical - Devices · US
$0.04
−13.99%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.1x
Market Cap
$231022.92
MomentumView details →
1D Return
−13.99%
YTD Return
−98.21%
RSI (14)
32.2
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.1x
Market Cap
$231022.92
RSI (14)
32.2
MomentumView details →
1D Return
−13.99%
YTD Return
−98.21%
SummaryUpdated Mar 1, 2026
Vicarious Surgical Inc. (NYSE:RBOT) is a medical device company founded in 2014 and headquartered in Waltham, Massachusetts. The company went public through a SPAC merger in September 2020. Vicarious Surgical is developing revolutionary single-incision surgical robotics technology that aims to transform minimally invasive surgery by virtually transporting surgeons inside the patient's body. The company is currently in the pre-commercial stage, having completed development of its Version 1.0 surgical system and preparing for its first clinical trials in 2025.
Similar companies
Latest newsMore news →
Vicarious Surgical shareholders voted to shut down and liquidate the company immediately.45d agoVicarious Surgical's board of directors proposes to dissolve and liquidate the company, seeking shareholder approval at a special meeting on July 21, 2026.51d agoSarah Romano resigned as Chief Financial Officer of Vicarious Surgical Inc., effective July 22, 2026.73d ago